Managing and leading a national team calling into public and commercial customers in the buy/bill injectable product segment. 2 Director level direct reports and 4 account manager direct reports supporting end-to-end commercialization of new vaccine product launch.Collaboration with commercial leadership, marketing, policy, advocacy, legal for the successful launch of vaccine to market.Additional individual responsibility of contract negotiations of CDC, FSS, TPR, 340-B and several public health PBGs.

Responsible for the development and growth within the Public Health customer segment within 11 states in the vaccine industry.IDN, C-Suite, CDC, Awardee jurisdictions. Built out of public health contracts for market access into public sector and training of new and existing field account managers.

Contract negotiations in the generic pharmaceutical sector in the IDN channel supporting 4 states.

GSK acquired Novartis Vaccine division.

Responsible for sales territory for a new vaccine within a new division of Novartis Vaccines. Account based direct sales to hospitals, health departments, universities and travel clinics. Customizing contracts and orders to each account to maximize the potential of each account. This division was sold to GlaxoSmithKline.-Signed 1st National IDN agreement for NVD -Elite Circle Winner -Various Michigan and Ohio territory responsibility-Central Region Advisory Board-National Contract Analyst Northeast Region- Stretch Role

4 promotions in the field sales team, training and contract analyst rolesBuy/ Bill injectables in the IDN, FQHC, LHD, Awardees, VA Sales Achievement Winners Circle AwardsRegional Contract AnalystField Sales Trainer